" /> Linagliptin - CISMeF





Preferred Label : Linagliptin;

NCIt synonyms : 8-((3R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-3,7-Dihydro-1H-Purine-2,6-Dione; (R)-8-(3-Amino-Piperidin-1-yl)-7-but-2-ynyl-3-Methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione; 1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-;

NCIt definition : A potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. The inhibition of DPP-4 by linagliptin appears to be longer lasting than that by some other DPP-4 inhibitors tested.;

UNII : 3X29ZEJ4R2;

InChIKey : LTXREWYXXSTFRX-QGZVFWFLSA-N;

CAS number : 668270-12-0;

Drug name : Tradjenta;

Molecule name : BI 1356 BS; BI-1356;

Chemical formula : C25H28N8O2;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
22/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.